Cariprazine Completed Phase 2 Trials for Schizophrenic Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00839852A Study of Cariprazine in Patients With Chronic Stable Schizophrenia
NCT00694707Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia
NCT00404573Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia
NCT00862992Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia